Spironolactone
Product Images NDC 42254-183

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 42254-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1b1a17a3-figure-01 (C22b0765 1777 4001 836a 2684daf2a35b 01)

1b1a17a3-figure-01 (C22b0765 1777 4001 836a 2684daf2a35b 01)
Chemical structure of spironolactone, showing its steroidal core with attached functional groups, including a lactone ring and a thioacetyl group. The molecular weight is indicated as 416.57.*
FDA Label Image

1b1a17a3-figure-02 (C22b0765 1777 4001 836a 2684daf2a35b 02)

1b1a17a3-figure-02 (C22b0765 1777 4001 836a 2684daf2a35b 02)
A Kaplan-Meier survival curve chart comparing probability over months for Spironolactone versus placebo groups. The x-axis represents time in months, and the y-axis shows probability. Two survival lines are indicated, one for Spironolactone (n=822) and one for placebo (n=841), with a log-rank p-value of less than 0.001.*
FDA Label Image

1b1a17a3-figure-03 (C22b0765 1777 4001 836a 2684daf2a35b 03)

1b1a17a3-figure-03 (C22b0765 1777 4001 836a 2684daf2a35b 03)
A forest plot illustrating hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups analysing the effect of Spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin, ACE inhibitor, and beta blocker usage. The x-axis ranges from 0.2 to 1.4, indicating relative benefit toward Spironolactone or placebo.*
FDA Label Image

1b1a17a3-figure-04 (C22b0765 1777 4001 836a 2684daf2a35b 04)

1b1a17a3-figure-04 (C22b0765 1777 4001 836a 2684daf2a35b 04)
Spironolactone 25 mg tablets packaging label by Rebel Distributors Corp. The white bottle label includes the product name, strength, dosage form, and labeler information, along with the NDC: 42254-183. The label features green and white colors with clear text displaying the medication and regulatory information.*
FDA Label Image

Spironolactone 25mg (C22b0765 1777 4001 836a 2684daf2a35b 05)

Spironolactone 25mg (C22b0765 1777 4001 836a 2684daf2a35b 05)
Spironolactone 25 mg tablets packaging label from Physician Partner, a division of Rebel Distributors Corp. The label shows the product name, strength, quantity (#30 tablets), and active ingredient Spironolactone USP 25 mg. It includes manufacturer details (Actavis Elizabeth LLC) and storage instructions to keep at controlled room temperature. The label also displays Product ID QS018330 and cautions to keep medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.